IMV Inc.
IMV
Rang în acțiuni
#35151
IMV Inc. is a clinical-stage biotechnology company dedicated to the development... IMV Inc. is a clinical-stage biotechnology company dedicated to the development of innovative immunotherapies. The company utilizes its proprietary DPX immune-educating technology platform to create a portfolio of treatments for various solid and hematological cancers. Its leading investigational drug, maveropepimut-S, is a DPX-based immunotherapy designed to target cancer cells that express survivin. Maveropepimut-S is currently undergoing Phase II clinical trials for diffuse large B-cell lymphoma, ovarian cancer, and specific bladder, liver, and microsatellite instability-high tumors, with Phase I trials also active for breast cancer. Beyond its primary candidate, IMV is also advancing DPX-SurMAGE, which is in Phase I clinical trials for bladder cancer, and is developing DPX-COVID-19 and DPX-RSV to address infectious diseases. Originally founded in 2000 as Immunovaccine Inc., the company adopted the name IMV Inc. in May 2018 and operates from its headquarters in Dartmouth, Canada.
Preț acțiune
$0.82959892
Ultima sincronizare: 2023-05-23
Capitalizare de piață
$4.16M
Schimbare (1 zi)
-0.04%
Schimbare (1 an)
82,959,792.06%
Țară
CA
Tranzacționează IMV Inc. (IMV)
Categorie
Healthcare
Istoricul spliturilor pentru IMV Inc. (IMV)
Acțiunea IMV Inc. (simbol: IMV) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Oct 21, 2026.
O acțiune IMV cumpărată înainte de Oct 21, 2026 este echivalentă astăzi cu 0 acțiuni IMV.
Cel mai recent split a avut loc pe Oct 21, 2026.
O acțiune IMV cumpărată înainte de Oct 21, 2026 este echivalentă astăzi cu 0 acțiuni IMV.
Listă splituri acțiuni
| An | Split | Multiplu | Multiplu cumulativ |
|---|---|---|---|
| Nu sunt suficiente date pentru perioada selectată. | |||
Splituri pentru companii similare sau competitori
| Companie | Număr total de splituri | Multiplu cumulativ | Țara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|